Inhibition of PCSK9 in high-risk patients. Less c-LDL is more. Rev. Fed. Arg. Cardiol. [Internet]. 2021 Jun. 2 [cited 2026 Oct. 5];48(1):3-5. Available from: https://www.revistafac.org.ar/ojs/index.php/revistafac/article/view/48